Nurix Therapeutics, Inc. (NRIX)
22.16
-0.19
(-0.85%)
USD |
NASDAQ |
Oct 12, 16:00
22.55
+0.39
(+1.76%)
After-Hours: 04:46
Nurix Therapeutics Gross Profit Margin (Quarterly) : 0.00% for Aug. 31, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2026 | 0.00% |
| May 31, 2026 | 57.43% |
| February 28, 2026 | 39.60% |
| November 30, 2025 | 65.89% |
| August 31, 2025 | 36.66% |
| May 31, 2025 | 88.43% |
| February 28, 2025 | 77.63% |
| November 30, 2024 | 67.61% |
| August 31, 2024 | 67.06% |
| May 31, 2024 | 66.17% |
| February 29, 2024 | 76.56% |
| November 30, 2023 | 75.22% |
| August 31, 2023 | 81.68% |
| May 31, 2023 | 89.13% |
| February 28, 2023 | 74.93% |
| November 30, 2022 | 55.23% |
| Date | Value |
|---|---|
| August 31, 2022 | 73.26% |
| May 31, 2022 | 76.98% |
| February 28, 2022 | 76.58% |
| November 30, 2021 | 89.76% |
| August 31, 2021 | 0.00% |
| May 31, 2021 | 0.00% |
| February 28, 2021 | 0.00% |
| November 30, 2020 | 0.00% |
| August 31, 2020 | 0.00% |
| May 31, 2020 | 0.00% |
| February 29, 2020 | 0.00% |
| November 30, 2019 | 0.00% |
| August 31, 2019 | 0.00% |
| May 31, 2019 | 0.00% |
| February 28, 2019 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 79.81% |
| ACADIA Pharmaceuticals, Inc. | 90.81% |
| Alnylam Pharmaceuticals, Inc. | 76.88% |
| Anika Therapeutics, Inc. | 65.15% |
| Savara, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 53.36% |
| Return on Assets | 41.05% |
| Return on Invested Capital | 48.23% |
| Profit Margin (Quarterly) | 81.69% |
| Operating Margin (Quarterly) | 83.12% |
| Return on Net Operating Assets | 390.0% |